Clinical Trial Detail

NCT ID NCT04096417
Title Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Academic and Community Cancer Research United
Indications

colorectal cancer

Therapies

Pemigatinib

Age Groups: adult senior

Additional content available in CKB BOOST